rcca-header
Clinical Trials

A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Obinutuzumab Compared to Chlorambucil in Combination with Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

Type of Cancer
Leukemia
Phase
Division (Location)
East Brunswick, NJ
Study ID
NCT#
Brief Description
A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Obinutuzumab Compared to Chlorambucil in Combination with Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.